Director, Pathology Drug Safety Research and Evaluation (DSRE), Head of Investigative Pathology
Initial Therapeutics, Inc.

Assistant Professor of Immunology – Dana-Farber Cancer Institute and Harvard Medical School
Dana-Farber Cancer Institute
